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The explosion of sequence information in bacteria
makes developing high-throughput, cost-effective
approaches to matching genes with phenotypes
imperative. Using E. coli as proof of principle, we
show that combining large-scale chemical genomics
with quantitative fitness measurements provides
a high-quality data set rich in discovery. Probing
growth profiles of a mutant library in hundreds of
conditions in parallel yielded > 10,000 phenotypes
that allowed us to study gene essentiality, discover
leads for gene function and drug action, and under-
stand higher-order organization of the bacterial
chromosome. We highlight new information derived
from the study, including insights into a gene
involved in multiple antibiotic resistance and the
synergy between a broadly used combinatory antibi-
otic therapy, trimethoprim and sulfonamides. This
data set, publicly available at http://ecoliwiki.net/
tools/chemgen/, is a valuable resource for both the
microbiological and bioinformatic communities, as
it provides high-confidence associations between
hundreds of annotated and uncharacterized genes
as well as inferences about the mode of action of
several poorly understood drugs.INTRODUCTION
Before the physical basis of genes was understood, associating
phenotypes with a heritable unit laid the foundation of modern
genetics. Following discovery of the genetic code, linking aphenotype to the responsible gene remained the most expedi-
tious way to unravel gene function. With the explosion of
sequence information, the balance has shifted. We now have
many genes of unknown function. To capitalize on the burgeon-
ing sequence bank, it is imperative to develop high-throughput
technologies that link genes to phenotypes and expedite
discovery of gene function. This is particularly true for prokary-
otes, which represent a major fraction of the sequenced
genomes and are in the forefront of metagenomic efforts (Qin
et al., 2010).
Chemical and environmental perturbations have traditionally
linked phenotypes to genotypes through forward genetic
screens, but reverse genetic approaches are being increasingly
utilized (Barker et al., 2010). Phenotype microarrays utilize
a high-resolution readout of cellular respiration to evaluate
fitness of a strain in hundreds of conditions (Bochner, 2009).
This approach is appropriate for studying a few strains but is
difficult to expand to genome-scale screens. In pooled growth
competitions, thousands of strains are assayed in a single
culture environment. Fitness values are derived from measuring
strain abundance in a test relative to control condition (Giaever
et al., 2004; Girgis et al., 2009; Hillenmeyer et al., 2008; Hoon
et al., 2008; Lee et al., 2005; Pan et al., 2004; Parsons et al.,
2006; Warner et al., 2010; Xu et al., 2007). These approaches
are very efficient, but competition between strains in each condi-
tion makes it difficult to determine relative strain growth across
conditions (Girgis et al., 2009), especially for strains that grow
slowly even in the absence of perturbation (Lee et al., 2005).
Arraying mutant strains on solid media allows independent eval-
uation of strain fitness but has been used only for low-resolution
measurements of entire libraries (Liu et al., 2010; Tamae et al.,
2008) or for essential genes (Pathania et al., 2009). High-
throughput genetic interaction studies, pioneered in yeast
(Schuldiner et al., 2005; Tong et al., 2001), are complementary
to chemical genomics approaches. Such analyses quantitativelyCell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc. 143
measure colony growth of double mutants in high-density format
on agar surfaces and have led to numerous successes in identi-
fying gene function and network organization (Beltrao et al.,
2010). Similar methodology has been developed for E. coli
(Butland et al., 2008; Typas et al., 2008).
We use E. coli to illustrate the power of applying the high-reso-
lution quantitative fitness measurements of genetic interaction
analysis to high-throughput phenotypic analysis of culturable
microbes. ‘‘Phenomic profiling’’ provides a quantitative descrip-
tion of the response of all single-gene deletions to physiologically
relevant stresses and drug challenges. By profiling4000 genes
in > 300 perturbations, we identified thousands of phenotypes
and a diverse suite of conditionally essential genes. This
approach provides new insights into the chromosome organiza-
tion, functional landscape, and evolutionary trajectory of E. coli.
It facilitates high-confidence association of genes of unknown
function to those of known function, as highlighted by discovery
of the role of a gene involved in multiple antibiotic resistance in
this manuscript and identification of two lipoproteins essential
for peptidoglycan synthesis (Typas et al., 2010). Finally, the
degree to which various gene deletions alter toxic drug effects
has led to powerful insights regarding drug mode of action
(Kohanski et al., 2008), and we demonstrate that our analysis
generates numerous leads concerning drug function.
RESULTS AND DISCUSSION
Phenomic Profiling of E. coli K12 Yields a Robust,
High-Quality Data Set
We determined quantitative growth scores for the Keio single-
gene deletion library (Baba et al., 2006); essential gene hypo-
morphs (C-terminally tandem-affinity tagged [Butland et al.,
2005] or specific alleles); and a small RNA/small protein
knockout library (Hobbs et al., 2010) in conditions representing
the range of stresses that E. coli encounters. Mutant strains
arrayed in high density on agar plates (1536 colonies/plate)
were grown in 324 conditions covering 114 unique stresses (Fig-
ure 1A and Figure S1A and Table S1 available online). Colony
sizes were analyzed and converted to a drug-gene score using
an approach developed for quantifying genetic interactions
(see Extended Experimental Procedures). More than half of the
conditions were antibiotic/antimicrobial treatments (Figure 1A).
By using a subinhibitory concentration series that maximally in-
hibited growth of the wild-type (WT) strain % 50%, we were
able to search for specific drug-gene interactions (Figure S1A)
and reduce the ability of spontaneous suppressor mutations to
overtake the colony. Two independently derived clones of
each mutant strain were analyzed (for sRNA mutants, a single
isolate was arrayed twice), and screens were performed at least
twice, enabling scores to be based on four to six independent
measurements. Correlation between replicate colony size
measurements was very high (r = 0.77; Figure 1B). The final
data set (Table S2) was comprised of scores for the 3979 mutant
strains passing quality control (e.g., proper normalized colony
size distribution and replicate reproducibility; see Extended
Experimental Procedures). The entire data set is available in an
interactive, searchable format and as a flat file on the E. coli
wiki website (at http://ecoliwiki.net/tools/chemgen/).144 Cell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc.The entire matrix (3979 mutants 3 324 conditions) was sub-
jected to two-dimensional (2D) hierarchical clustering (Fig-
ure 1C). Drugs with similar effects cluster on the x axis; mutants
that behaved similarly cluster on the y axis. Notably, concentra-
tions of the same drug, drugs of the same family, and/or similar
conditions clustered together, as did mutants of genes known to
be part of the same operon, biological pathway, and/or protein
complex. Zoomed insets of our clustergram illustrate examples.
Genes in the rfa operon (rfaG, rfaP, rfaQ, rfaB and rfaI), which
encodes enzymes that synthesize the inner- and outer-lipopoly-
saccharide (LPS) core, strongly cluster together with three/four
genes that are responsible for the synthesis of one of the sugar
building blocks, ADP-L glycero-b-D-manno heptose (rfaD, rfaE,
and lpcA). Importantly, clustering reflects their shared sensitiv-
ities to a concentration series of compounds known to perturb
the envelope integrity of the cell, consistent with the role of
LPS. dsbA and dsbB, encoded in different operons, also cluster.
The DsbA/DsbB complex generates disulfide bridges in the
periplasm.
The response of each mutant strain across all conditions is
denoted as its ‘‘phenotypic signature.’’ High correlation between
two phenotypic signatures is highly predictive of known indica-
tors of functional connection between genes. Gene pairs with
correlation coefficients (r) between 0.6 and 0.8 (p < 1034) are
more than 100-fold enriched for genes sharing common operon
membership and 150-fold enriched for genes with known protein
interactions determined from low-throughput experiments
(http://www.ecocyc.org; Figure 1D). This benchmarking analysis
indicates that our phenomics data set is biologically meaningful.
Correlated phenotypic signatures also reproduce connections
between curated biological pathways (Figure S1B). For example,
electron transfer components cluster tightly (e.g., nuo genes
encoding NADH dehydrogenase I complex; Figure 1C). Their
clustering reflects high sensitivity to membrane-perturbing
stresses, including detergents, dyes, and metals, and increased
resistance to aminoglycosides, in agreement with early studies
that illustrate decreased aminoglycoside uptake in the absence
of a fully functional electron transport chain (Girgis et al., 2009;
Taber et al., 1987). All three examples described in Figure 1C
are consistent with the expectation that highly correlated pheno-
typic signatures are biologically meaningful (rR 0.60.8).
Phenomic Profiling Defines Responsive
and Conditionally Essential Genes
A central goal of this study was to systematically evaluate the
impact of every gene deletion on E. coli fitness in diverse envi-
ronments, as few gene deletions in E. coli have robust reported
growth phenotypes, and only 8% of the genes are essential in
rich media (Baba et al., 2006; Yamamoto et al., 2009). We
used a statistical method to define a reliable phenotype. In brief,
we standardized the interquartile range of the distribution of
scores for each screen and then determined the probability
that each condition-gene interaction represented a true pheno-
type using a normal cumulative distribution function (see
Extended Experimental Procedures). Using a 5% probability
that these phenotypes arose by chance as a cutoff (false
discovery rate [FDR] % 5%), 49% of all strains tested (1957/
3979 strains; Figure 2A) had one or more phenotypes. We refer
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Figure 1. Phenomic Profiling of the Enhanced Keio Collection Yields a Robust and Rich Data Set
(A) Classification of the 324 stresses screened (left) and cellular targets of the antibiotic/antimicrobial/drug classes (right).
(B) Heat map representation of scatter plot comparing normalized colony sizes in pixels of plate replicates 1 and 2 across the entire data set. Bins indicate the
square root of the number of replicate pairs within a 10310 pixel window as depicted by color scale. Note that the vast majority of the replicates have highly
correlated colony sizes.
(C) Clustergram of fitness scores for 3979 mutant strains in response to all 324 conditions. Zoomed insets demonstrate coclustering of conditions (x axis) and
genes (y axis) for a common pathway (rfa cluster) and protein complexes encoded in the same operon (nuo) or in different operons (dsbA and dsbB). Gray boxes
indicate missing data.
(D) High correlation between a pair of phenotypic signatures is predictive of shared protein interaction and/or operon membership.
See also Figure S1, Table S1, and Table S2.to these genes as the ‘‘responsive genome.’’ This responsive
genome is a work in progress, as it is limited to genes whose
removal causes growth phenotypes in response to the stresses
tested. Expanding the stresses tested and/or the readout (e.g.,
motility) will certainly increase this number (Girgis et al., 2007).
A cumulative plot of the number of individual phenotypes per
strain shows that very few genes have many phenotypes.
Multi-stress responsive (MSR) strains (R30 phenotypes; Table
S3) participate in many cellular processes, suggesting that our
stresses encompassed diverse cellular challenges (Figure 2B).
With a stringent cutoff of 5% FDR, the maximum number of
phenotypes from a single screen was 173 (4% strains; Fig-
ure S2A), and the total number of phenotypes (13497) represents
1% of all condition-gene pairs tested. Overall, 80% of the
phenotypes were negative (gene deletion more sensitive) and
20% positive (gene deletion more resistant), consistent withrecent genetic interaction analyses in S. cerevisiae (Fiedler
et al., 2009) and S. pombe (Roguev et al., 2008). This suggests
that removal of a gene product is more likely to decrease than
enhance resistance to stress (Figure S2B). In summary, our
analysis captured numerous highly specific condition-gene
responses. Clearly, this data set can be used to assign more
phenotypes at a lower confidence level. Indeed, a recent chem-
ical genomics data set in S. cerevisiae reported phenotypes for
more than 95% of gene deletions tested, many stemming from
a handful of severe stresses (Hillenmeyer et al., 2008).
Conditionally essential (CE) genes are essential for growth in
a particular condition. Deletions of such genes shows very small
colony sizes and high-confidence negative scores in particular
conditions (see Extended Experimental Procedures). We identi-
fied 197 CE genes, comprised of auxotrophs, which exhibit no
growth in minimal media, and rich-media CE genes, whichCell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc. 145
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Figure 2. Identification of Responsive and Conditionally Essential Genes
(A) Using a 5% false discovery rate (FDR), 49% of strains tested had at least one phenotype (open circle on the red line). As the FDR is relaxed, more phenotypes
are identified (red line). At 5% FDR, some strains have several phenotypes (black), and very few (2.3%; 94 strains) have 30 or more phenotypes (green,
multi-stress responsive [MSR] genes).
(B) MSR genes participate in a wide variety of cellular processes, particularly those related to metabolism and the cell envelope. Genes were manually curated to
COG-based functions; each gene was allowed to belong only to a single function.
(C) 196 genes are conditionally essential (CE) in this study. Of these, roughly half have been previously described as CE due to auxotrophy. Note that some
auxotrophic genes also display a no growth phenotype in at least one rich medium condition and are classified jointly as auxotroph and rich media CE.
(D) CE gene products are enriched in the outer cell envelope (periplasmand outermembrane) relative to Keio essential genes (p = 0.00026), highlighting the impor-
tance of this compartment in tolerating stress. The cytoplasmic gene category is not displayed here but is not enriched for CE gene products.
See also Figure S2, Table S3, Table S4, and Table S5.exhibit no growth in at least one rich media-based stress (Table
S4). Importantly, our data set had 70% overlap with a previous
study of Keio Collection auxotrophs (Figure 2C; Joyce et al.,
2006) despite significant experimental differences (e.g., growth
in liquid versus solid media). Many of the remaining 30% were
extremely sick but above the stringent threshold that we used
to define no growth. We also identified 23 additional auxotrophs
specific to alternative carbon/nitrogen sources that were not
tested in the Joyce et al. study.
Genes that are essential for survival in natural environments
are likely to extend beyond those required for laboratory growth
and could be targets for new antimicrobials (D’Elia et al., 2009).
The 116 rich-media CE genes that we identified (Figure 2C) result
from physiologically relevant stresses and increase the current
number of essential genes by roughly 30%. Interestingly, many
of these gene products are located in the outer cell envelope146 Cell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc.(Figure 2D), a selective permeability barrier for Gram-negative
bacteria that is severely underrepresented for known essential
genes (Figure 2D). Many of the stresses generating CE pheno-
types are part of the natural environment of E. coli, e.g., bile salts
(Table S5), indicating that these genes are likely indispensable
for E. coli to survive in vivo. Similarly, using the largest metage-
nomic data set to date, Qin et al. reported that envelope-specific
functions, such as adhesion, were commonly required for life in
the gut (Qin et al., 2010).
Phenomic Profiling Helps Assign Function
to Uncharacterized Genes
A key motivation for our study was to provide phenotypes for
mutants of genes without functional annotation. Using a recently
assembled compendium of such ‘‘orphan genes’’ in E. coli (Hu
et al., 2009), we find that the fraction of mutant orphan genes
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Figure 3. Phenomic Profiling Identifies Phenotypes for Orphan Gene Mutants
(A) Cumulative distribution of phenotypes indicating the fraction of genemutants in each class having at least the number of phenotypes shown on the x axis. The
plot reveals that orphan genemutants have phenotypes but tend to have fewer phenotypes than annotated genemutants. The insert quantifies phenotype deficit
of orphan mutants.
(B) Cumulative distribution of highly correlated pairs identifies many orphan genes that correlate highly to an annotated gene, providing high-confidence clues to
the function of the orphan gene. Values shown above each pair of bars are the p values associated with pairwise correlation of any two strains at the indicated
correlation coefficients.
(C) High-confidence correlations between orphans and annotated genes (rR 0.5) provide leads that are related to many different cellular functions. Procedure
for functional assignment is described in Figure 2. Note that several ‘‘annotated genes’’ were classified as genes of ‘‘unknown function’’ or ‘‘general function
prediction only’’ after manual curation.
(D) Annotated genes that are responsible for many phenotypes tend to be broadly conserved, whereas themost responsive orphan genes tend to be restricted to
g-proteobacteria. For a list of the orphans-annotated pairs (r > 0.5), see Table S6.with phenotypes is close to that of annotated genes (Figure 3A),
but the former tend to have fewer phenotypes, indicating the
power of phenomic analysis for identifying their phenotypes.
Importantly, the phenotypic profiles of > 25%of all orphan genes
correlate strongly with those of annotated genes (r R 0.5; Fig-
ure 3B and Table S6), providing high-confidence leads (p <
1022) for discovery of their function. As these orphans are tied
to a wide variety of cellular processes (Figure 3C), the data set
will be of broad utility.A small fraction of orphan gene knockouts have many pheno-
types. Whereas annotated genes that are responsible for many
phenotypes are broadly distributed among bacteria, the most
responsive orphans tend to be narrowly distributed (Figure 3D).
This result suggests that evolutionary conservation is not a
reliable indicator of the importance of an orphan gene to the
organism and that annotating them solely by homology has limi-
tations. Such orphans may have evolved to fulfill an important
but specialized function required by the niche of the organism.Cell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc. 147
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Figure 4. A Function for marB
(A) marR and marB phenotypic signatures are highly correlated with each other and are highly anticorrelated with that of acrB (top). The bottom graph
positions these correlations in a histogram showing all pair-wise correlation coefficients between the 3979 mutants.
(B) Schematic of the E. colimultiple antibiotic resistance (mar) operon.marB is a gene of unknown function, but our results suggest that it encodes a protein that
inhibits MarA.
(C) RT-PCR analysis shows that marA transcription is derepressed in marB cells. Derepression is independent of and additive with that of marR.In support of this idea, a multiresponsive orphan identified in this
study (lpoB) is restricted to enterobacteria and regulates pepti-
doglycan synthesis, a conserved process that is ubiquitous
among bacteria (Typas et al., 2010).
Using Phenotypic Signatures to Identify Gene Function
Both correlated phenotypic signatures (Figures 1C and 1D;
Typas et al., 2010) and anticorrelated phenotypic signatures
have functional significance. For example, the phenotypic signa-
tures of deletions of a transcriptional repressor and important
target genes are likely to be anticorrelated. We find that marR
and marB were highly anticorrelated with acrB, whereas
marR and marB were highly correlated (Figure 4A). marB is
a gene of unknown function in the multiple antibiotic resistance148 Cell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc.operon (marRAB), which also includes the operon repressor
marR and its activator, marA. MarA also activates genes
involved in antibiotic resistance, most importantly acrAB, en-
coding the major antibiotic efflux pump in E. coli (Figure 4B)
(Martin and Rosner, 2002). We explored whether MarB, like
MarR, repressed MarA. Because of the inherent problems of
high-throughput collections (suppressors, gene duplications,
and cross-contamination), we always apply stringent quality
control procedures to any follow-up investigations, including
PCR validation of Keio isolates and verification that retrans-
duced strains maintain their phenotype. As mar is a hot spot
for adaptive mutations, we also sequenced the entire operon
and promoter region of single deletions and the double mutants
that we constructed.
Deletion of eithermarB ormarR resulted in higher MarA levels,
and the double-marRBmutant showed additive effects on MarA
transcript level (Figure 4C) and protein level (data not shown).
These effects were observed in both Kan-marked and clean
deletions (Kan cassette excised, leaving an 82 nt scar). The
DmarR strain exhibits 23 more increase in MarA transcript
levels thanmarR::kan (data not shown), arguing for a small polar
effect of the cassette. Both marB::kan and DmarB exhibit the
same 2-fold increase in MarA levels (data not shown). These
data suggest that MarB represses MarA independently of
MarR. MarB does not have the signature of a DNA-binding
protein, suggesting that it acts posttranscriptionally. MarA level
is controlled by the Lon protease (Griffith et al., 2004), but lon
and marB effects are additive, indicating that MarB does not
function through Lon (data not shown). MarA has been proposed
to scan for activation sites while bound to RNA polymerase; by
direct binding to either partner, MarB could disrupt complex
formation. Alternatively, MarB may function in the periplasm.
As MarB has a predicted periplasmic signal sequence, it could
titrate an activating ligand for mar (e.g., salicylate).
Although mar is highly studied (200 primary publications;
PubMed), our screen provided the first lead for MarB function.
MarA targets 40 genes, many of which are also coregulated
by the SoxS and Rob activators, with similar DNA-binding motifs
as MarA (Martin et al., 2008; Martin and Rosner, 2002). The rules
of engagement are poorly understood, but each activator
responds to different environmental cues, and overexpression
of each leads to distinct phenotypes (Warner and Levy, 2010).
It is likely that tight control of each activator has an impact on
the final gene expression output, which is crucial for cellular
proliferation. MarB may be an important player in fine-tuning
the expression of MarA, especially because it is a conserved
member of the mar operon, which has only recently emerged
in selected enterobacteria. Strong evidence for the importance
of mar operon regulation in these organisms is that mar is a hot
spot for mutations conferring higher drug resistance in E. coli
(Nicoloff et al., 2006, 2007).
Phenomic Profiling Reveals Metabolic Network
Behaviors under Antifolate Drug Stress
Tetrahydrofolate (THF) and its methyl/formylated derivatives are
key molecules in all kingdoms of life for one-carbon metabolism.
THF is used to synthesize glycine, methionine, purines, and
dTTP in a process that leads to recycling of the THF species
back to THF or dihydrofolate (DHF) (Figure 5A). The bacterial
THF biosynthesis pathway is targeted by two drugs: sulfon-
amides (Sulfa) target FolP, and trimethoprim (TMP) targets
FolA (Figure 5A). Dual inhibition by Sulfa and TMP is strongly
synergistic, and therefore these drugs are almost exclusively
administered in combination for treatment of ear, urinary tract,
and bronchial infections. Despite extensive clinical use and
years of laboratory investigation, we lack a complete mecha-
nistic understanding of why these drugs are strongly synergistic.
A network feature identified by phenomic profiling could
contribute to synergy.
We find that the two drug classes have major phenotypic
differences. Sulfa and TMP treatments are highly correlated
within their class (r = 0.57 for Sulfa, 0.67 for TMP) but poorlycorrelated with each other (r = 0.15 ± 0.04), just slightly more
than the correlation observed between all screens (r = 0.025 ±
0.12). Thus, subinhibitory TMP and Sulfa treatments have funda-
mentally different effects on the cell even though both partially
block THF biosynthesis. Importantly, removing enzymes acting
directly downstream of THF production resulted in opposite
drug sensitivities: the serine hydroxymethyltransferase mutant
(glyA::kan) was sensitive only to TMP; conversely, glycine
cleavage (GCV) mutants (gcvP::kan, gcvH::kan, and gcvT::kan)
were sensitive only to Sulfa (Figure 5B). The mutant results
were reproduced in liquid culture (Figure 5D), in which glyA
TMP sensitivity is manifested as a growth rate phenotype (left),
and gcvP sulfamethizole (SMT) sensitivity is registered as
a low stationary phase density (right).
GlyA and GCV lie on opposite sides of a branched pathway
that converts THF to 5,10-methylene THF (5,10-mTHF; Fig-
ure 5A). As glyA and gcv mutants exhibit synthetic lethality,
they are the only routes to production of this essential metabolite
(Figure 5C). A simple explanation for the differential responses of
glyA and gcvP is that 5,10-mTHF is predominantly produced
via different branches under each drug treatment. A corollary is
that combination drug treatment inhibits both branches, result-
ing in synergistic limitation for 5,10-mTHF, before the pools of
THF are depleted. In support of this idea, despite the increased
sensitivity of glyA and gcvP to single drugs, these strains grew
nomore poorly thanWT under the drug combination (Figure 5D).
Thus, genetically eliminating either branch of the pathway
reduced but did not eliminate synergy. The downstream biosyn-
thetic reactions are also differentially affected by TMP and Sulfa
(Figure S3A), and we are currently testing whether they partially
account for the residual synergy. Streptococcus pneumoniae
lacks the GCV system and exhibits significantly less drug
synergy than E. coli across different growth conditions (Figure 5E
and data not shown). We performed our comparison using
concentrations of TMP and SMT that caused the same relative
growth defect in each species (Figure 5E). These data together
support the hypothesis that simultaneous inhibition of the
branched pathway for production of 5,10-mTHF contributes to
the observed antifolate synergy in E. coli.
Our data do not indicate whether differential effects of TMP
and Sulfa on GlyA and GCV result from differential inhibition of
expression or activity or the intrinsic properties of each enzyme.
We favor the idea that differential metabolite accumulation and
subsequent feed-forward enzymatic regulationmake a contribu-
tion to the distinct cellular responses to these two drugs. Recent
metabolomic flux analyses indicate that high doses of TMP
lead to accumulation and depletion of select metabolites, as
well as to protein-level regulation of portions of the network
(Kwon et al., 2008, 2010). Although a comparable analysis has
not been performed for Sulfa drugs, deletion of the predicted
5-formyl-THF cycloligase, ygfA, which likely degrades
5-formyl-THF (Jeanguenin et al., 2010), clusters tightly with the
gcv mutants and exhibits sensitivity only to Sulfa drugs (Fig-
ure S3A). That 5-formyl-THF degradation is critical only under
Sulfa stress suggests differential accumulation (or requirement)
of THF species under Sulfa and TMP treatments. 5-formyl-THF
is a known inhibitor of several enzymes in the THF network of
other organisms (Field et al., 2006; Stover and Schirch, 1993)Cell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc. 149
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Figure 5. A New Network Feature Contributing to Antifolate Drug Synergy
(A) Schematic of the E. coli tetrahydrofolate (THF) biosynthesis pathway and the enzymatic steps inhibited by Sulfa and TMP.
(B) Clustergram of genes that respond to Sulfa, TMP, or the combination. Zoomed image indicates that gcvmutants are sensitive to Sulfa, that glyA is sensitive to
TMP, and that these four mutants exhibit essentially wild-type growth in response to the drug combination.
(C) glyA and gcvP are a synthetic lethal pair. Image of a plate mating between the donor Hfr gcvP::cat and 24 kanR recipients (arrayed in boxes of 838 colonies)
grown on kanamycin/chloramphenicol medium to select for double-mutant strains; position of the glyA::kan and gcvP::kan recipients is highlighted.
(D) Liquid culture experiments verify growth phenotypes on agar plates shown in Figure 5B. The deviation of the observed from the expected value for the TMP/
SMT combination denotes the degree of synergy of the two drugs, which is lower for glyA and gcvP cells compared to wild-type cells. Concentrations shown
for TMP and SMT are in mg/ml.
(E) Quantification of synergy in E. coli and S. pneumoniae, which lacks the branched pathway for generating 5,10-mTHF present in E. coli. Comparisons were
performed using single drug concentrations giving equivalent inhibition of both organisms. S. pneumoniae has reduced synergy compared to E. coli.
See also Figure S3.and could act as an effective protein-level regulator. Similarly,
a strain lacking a predicted alanine racemase, yggS, is sensitive
only to Sulfa; D-alanine is known to inactivate GlyA (Schirch150 Cell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc.et al., 1985), and yggS and glyA form a synthetic lethal pair
(Figure S3B). Thus, the different cellular responses to these
two drugs may be due, in part, to metabolite-based enzymatic
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Figure 6. Phenomic Profiling Generates Insights into Genome Organization
(A) Essential and responsive genes are biased to the plus strand of DNA (transcription direction coincident with replication), and the nonresponsive genes are
biased to the minus strand of DNA.
(B and C) For each panel, circular plots depict gene position, adjusting coordinates so that the chromosome starts at the origin of replication (oriC = 0 bp); the
terminus region (ter) is opposite the oriC. Each trace represents spatial enrichment for the variable plotted based on a 100 kb sliding window. Three dashed lines
of the same color accompany each trace, indicating the minimum permutation threshold, the baseline representing zero enrichment, and the maximum
permutation threshold (inside to outside). Permutation thresholds are the result of 1000 randomizations of gene class assignments (see Extended Experimental
Procedures) and indicate significant negative and positive spatial enrichment at a p value of 0.05.
(B) Responsive and CE genes are concentrated around the oriC and scarce around the terminus.
(C) The terminus is positively enriched for genes restricted to the g-proteobacteria and negatively enriched for broadly conserved genes.
See also Figure S4.regulation. An extension is that the synergy of combination
therapy could rest primarily on complementary inhibition of
different one-carbon biosynthesis reactions and therefore recy-
cling of THFs. This model would allow for synergy even with the
expected additive limitation of THF production.
In summary, our results illustrate the power of phenomic
profiling to yield insights into drug action and the ability of
a networks view to provide new paradigms for analysis of drug
interaction mechanisms, which can facilitate hypothesis-driven
research on drug interactions (Bollenbach et al., 2009). This
type of analysis may be generally useful in predicting drug syner-
gies and in explaining variable drug-drug interactions across
species.
Phenomic Profiling Gives Insights into Genomic
Organization
TheE. coli genome is encoded on a single, circular chromosome,
with a single origin of replication, oriC. Essential genes are
biased to the plus (+) strand, where transcription proceeds in
the same direction as DNA replication. This may avert head-on
collisions between RNA and DNA polymerases that would result
in aborted transcripts or truncated or frame-shifted proteins (Ro-
cha and Danchin, 2003). Here, we show that responsive and CE
genes, which are important for optimal growth of the organism,
also show + strand bias (Figure 6A). Indeed, the weightedresponsive genome (responsive genes weighted by number of
phenotypes identified) is heavily biased to the + strand, indi-
cating great selective pressure to place genes that are important
for rapid growth on the + strand. Conversely, the nonresponsive
genome is biased to the minus () strand. As our approaches
expand to incorporate additional phenotypic readouts that are
more important for cells with reduced division and DNA replica-
tion (e.g., biofilm formation), the + strand bias of responsive
genes will presumably be reduced.
The chromosome is massively compacted in the cell to create
the nucleoid, which is thought to contribute significantly to the
organization of gene expression (Travers and Muskhelishvili,
2005; Vora et al., 2009). Chromosomal loci have spatial
addresses in the cell, corresponding closely to their chromo-
somal position (Toro and Shapiro, 2010). In addition, highly
expressed genes that are associated with transcription and
translation are located near the origin of replication (oriC),
presumably to benefit from the ‘‘gene dosage’’ effect created
when rapidly growing cells initiate multiple rounds of DNA repli-
cation per division (Couturier and Rocha, 2006). Projecting the
spatial distribution of the responsive genes onto the circular
chromosome (Figure 6B, black trace) provides us with a snap-
shot of the E. coli genome from a functional perspective. This
projection is based on a 100 kb sliding window and therefore
captures organization above the operon level (Figure S4A andCell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc. 151
Extended Experimental Procedures). A pattern of alternating
peaks and valleys is clearly evident, indicating that responsive
genes cluster spatially into large chromosomal regions that are
separated by regions generally devoid of responsive genes.
‘‘Valleys’’ are comprised of spatially separated operons that
are often transcribed from different strands, indicating that low
responsiveness is a regional characteristic rather than an artifact
due to large nonresponsive operons. Our finding of clustering
above the operon level is in accord with other studies showing
that gene expression is broadly correlated across certain regions
of the chromosome (Carpentier et al., 2005; Jeong et al., 2004).
The responsive genome is most enriched around oriC, which
has the highest concentration of responsive genes (Figure 6B,
black trace). This area is also enriched for the most responsive
genes (Figure S4B) and for CE genes (Figure 6B, red trace),
providing strong support for the idea that the E. coli chromosome
tends to store genes of high functional importance near the oriC.
In contrast, the terminus region is relatively devoid of responsive
genes (Figure 6B, black trace) and has a paucity of broadly
conserved genes (Figure 6C, red trace) and a corresponding
enrichment for genes restricted to g-proteobacteria (Figure 6C,
blue trace). We postulate that the terminus region contains newly
acquired genes that have yet to fully integrate into the cellular
network and tend to lack phenotypes. This could enable cells
to avoid unnecessarily high expression of suchgenes as a conse-
quence of the gene dosage effect. Should this result prove true
across bacterial species, it could point to a general organizing
principle of circular chromosomes.
Phenomic Profiling Describes Drug Action
‘‘Drug-centric’’ analyses are more complex than ‘‘gene-centric’’
analyses.Whereas genesmostly participate in a single biological
process, many parameters are required to describe drug action:
uptake, primary/secondary targets, and efflux. Therefore, pair-
wise relationships between drugs are more complex than those
between genes. For example, two drugs may cluster based on
drug uptake even though their primary targets differ. In addition,
drug signatures are an order of magnitude larger than gene
signatures (3979 versus 324). To reduce the complexity of drug
signatures, we calculated drug-gene ontology (GO) scores,
which represent the probability that a given GO group specifi-
cally interacts with a given drug (i.e., number of phenotypes
associated with genes in the GO group versus across the entire
data set). We used these drug-GO scores to explore drug mode
of action through a network-based clustering strategy (see
Extended Experimental Procedures). The position of drugs in
the network (Figure 7A) is based both on the magnitude of
their drug-gene ontology (GO) scores (gray) and on drug-drug
correlations (yellow). Of the 719 significant drug-GO interactions
(p % 103), which include 64 drugs and 218 GO groups, 657
were negative, and only 62 were positive. Thus, disrupting
a linked biological process was very likely to increase drug sensi-
tivity (Table S7). Drug-drug correlations increased the resolution
of the network and captured drug similarities that escaped the
drug-GO analysis.
We found that drugs with the same cellular target tend to
cluster. For example, drugs targeting DNA (orange) fall in the
lower right, those targeting THF-biosynthesis (light green) fall152 Cell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc.on the bottom edge, and those targeting peptidoglycan (PG;
purple) predominantly cluster in the upper left. Interestingly,
b-lactams cover the center of the PG cluster, whereas drugs
targeting other steps of PG synthesis are located at the
periphery. The correlation coefficients between b-lactams reveal
that the similarity of their phenotypic signatures is related to their
respective primary target penicillin-binding proteins (Figure S5A).
Interestingly, known synergistic double-drug combinations
(TMP/sulfonamides and mecillinam/cefsulodin) occupy spaces
that are distinct from either individual drug, arguing that the
combination elicits a different cellular response from the indi-
vidual drugs. It will be interesting to determine whether this holds
true for antagonistic or neutral interactions or whether these
combinations elicit responses closer to one or both drugs.
Importantly, specific drug-GO interactions suggest hypoth-
eses for mechanism of action even for well-studied drugs. Qui-
nolones inhibit DNA gyrase by trapping it as a quinolone adduct,
whose mechanism of resolution is poorly understood (Drlica
et al., 2008). One GO category, ‘‘cellular DNA catabolic process’’
(xseAB), selectively and specifically (p = 106) interacted
negatively with all four quinolones screened (Figure 7B and Fig-
ure S5B), expanding on a previous report of xseABmutant sensi-
tivity to fluoroquinolones (Tamae et al., 2008). We suggest that
XseAB (exonuclease VII) is the enzyme that cleaves quinolone-
bound DNA gyrase from the DNA to allow repair to proceed,
a possibility that we are currently exploring.
Our drug network also provides clues for the mode of action
of poorly described drugs and, conversely, suggests that addi-
tional factors are required to explain the action of other drugs.
Nitrofurantoin (NTF; Figure 7B) is reported to have a multifaceted
impact on cells (McOsker and Fitzpatrick, 1994; Tu andMcCalla,
1975), but our data suggest that its cytotoxic effects reflect DNA
damage, as it causes lesions requiring nucleotide excision repair
(NER) and activates the SOS response. NTF is the only DNA-tar-
geting drug requiring NER, but not double-strand break repair,
suggesting that itsprimary toxic lesion isassociatedwith the repli-
cation fork (Figure S5B). In addition, our network analysis vali-
dates the idea that indolicidin, a neutrophil antimicrobial peptide,
mediates its effects by compromising the inner-membrane
permeability of E. coli in a manner that is similar to the proton
motive force uncoupler, CCCP (Falla et al., 1996). Finally, phleo-
mycin and bleomycin do not cluster with DNA response drugs,
suggesting that they have broader cellular impact (Hecht, 2000;
Yeh et al., 2006) from inducing DNA scissions (Giloni et al.,
1981). These insights suggest that this phenomic data set is
a rich source for discovery of drug function and interrelationships.
Perspectives
To keep pace with exploding sequence information, cost-effec-
tive, high-throughput phenotyping technologies must be devel-
oped. Here, we show that phenomic profiling in E. coli fulfills
this goal. Our data set is of great utility in identifying the function
of orphan genes. Three cases (marB, lpoA, and lpoB) were inves-
tigated here or in a study based on this data set (Typas et al.,
2010), and we are actively pursuing functional discovery of
numerous (>20) orphan genes, as well as annotated genes
with previously unsuspected roles in collaboration with others.
Because > 25% of the orphan genes are highly correlated to
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Figure 7. Network View Reveals New Insights into Drug Action
(A) Colored nodes represent all drugs profiled in this study that were found to have significant interactionswith gene ontology (GO) biological process groups (gray
nodes). Connections between nodes represent significant drug-GO interactions (p% 103, gray) or high drug-drug correlation (rR 0.32; p% 1097, yellow). Drug
node size is based on the number of connections associated with that node, i.e., larger nodes have more drug-GO interactions. Spatial clustering is driven by the
p values of drug-GO interactions and drug-drug correlations, resulting in drugswith similar cellular action lying near each other in the network. Drugswithmultiple,
unknown, or poorly defined targets are shown in dark blue.
(B) Zoomed view of subnetwork shadowed by light blue box in (A). All four quinolones screened (orange) interact negatively with xseAB (exonuclease VII) and are
the only drugs that require the exonuclease; p = 106. NTF is found to activate the SOS response and create lesions requiring nucleotide-excision repair
(Figure S5B). Connections between nodes represent significant drug-GO interactions (p < 103, gray). For all drug-GO interactions, see Table S6.
See also Figure S5.an annotated gene (r R 0.5), this data set provides a rapid
method for function discovery.
An important finding is that the most responsive orphan genes
tend to be narrowly distributed among bacteria. Interestingly, our
results mirror initial observations from human microbiome
studies. These studies found that: (1) roughly half of the functions
encoded in the minimal gut metagenome (ubiquitously present in
all 124 individuals screened) are both unknown and of limited
evolutionary conservation (Qin et al., 2010), and (2) across four
pan-genome species analyzed, the vast majority of noncommon
genes were of either unknown function (70%) or were unique
family members of functions that were part of the core gene set
(Nelson et al., 2010). The latter are probably species-specific
additions to conserved biological processes of the pan-genome.
Together, these studies argue that,when computationalmethods
based on gene conservation fail, large-scale phenomic analyses
can be a second tier for assigning function. To make this
approach a reality, low-cost methods for developing deletionlibraries must be developed (Goodman et al., 2009). Single-
gene deletion ordered libraries are currently available for only a
handful of organisms (Cameron et al., 2008; de Berardinis et al.,
2008; Gallagher et al., 2007; Goodman et al., 2009; Kim et al.,
2010; Liu et al., 2008; Noble et al., 2010; references in Barker
et al., 2010), but advances in transposon mutagenesis make it
feasible to create ordered mutant libraries in most organisms. In
E. coli, expansion of this work will rest on the ability to assess
additional phenotypes through deeper exploration of phenotypic
space. The greatest potential resides at the intersection of
screening more diverse stresses and incorporating additional
cellular readouts. Colorimetric readouts would enable measure-
ment of transcriptional activity or biofilm formation on solid agar
surfaces and represent an immediate potential advance for phe-
nomic profiling. High-throughput microscopy would provide
a new avenue for such approaches (Werner et al., 2009).
Our data set provides information on a substantial collection
of antibiotics/antimicrobial compounds that cover a broadCell 144, 143–156, January 7, 2011 ª2011 Elsevier Inc. 153
spectrum of drug targets, structural classes, and drug genera-
tions, providing a platform for future studies focused on natural
products or antimicrobials with unknown targets. Our data set
can also provide a platform for studying the mechanism behind
drug interactions (Yeh et al., 2009), as shown here for the case
of sulfonamides and TMP. Understanding the mechanism
underlying known drug interactions may help to predict novel
interactions and manipulate existing drug combinations to
increase their effectiveness in the clinic.
In summary, we have generated a valuable resource for
microbiologists studying a wide range of biology and demon-
strated the numerous and diverse applications of this data set
to infer information on both gene and drug function. As, to our
knowledge, the most comprehensive prokaryotic chemical
genomic study to date (3979 strains 3 324 conditions), our
data set will serve as a base for future studies that aim to
increase information and/or resolution on both the gene and
drug fronts. We hope that the usefulness of this resource will
trigger analogous studies in other organisms, bringing us
a step nearer to closing the gene sequence-function gap.EXPERIMENTAL PROCEDURES
Experimental procedures are partially elaborated upon in the text and figure
legends and are fully explicated in the Supplemental Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and seven tables and can be found with this article at doi:10.1016/
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